Grade 3 Meningioma — Trials

Grade 3 Meningioma — Trials · CancerIndex

Clinical trials

Registered studies

41 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 10
Recruiting: 7
Ph III recruiting: 0
Growth YoY: —
Industry share: 10%
Top sponsor: Emory University
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (8)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06275919	Regorafenib for Recurrent Meningioma (MIRAGE Trial)(MIRAGE)	recruiting	Phase 2	104	Istituto Oncologico Veneto IRCCSOTHER	1	May 13, 2026	clinicaltrials
NCT04082520	Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy	recruiting	Phase 2	42	Mayo ClinicOTHER	1	Apr 22, 2026	clinicaltrials